Systemic adverse effect of antithyroid drugs

Clinical Rheumatology

Volumn 18, Issue 1, 1999, Pages 66-68

  Mathieu, E ^a,b   Fain, O ^b   Sitbon, M ^b   Thomas, M ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

Hyperthyroidism; Polyarthritis; Propylthiouracil; Vasculitis

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CROSS REACTION; FEMALE; HUMAN; HYPERTHYROIDISM; LUPUS ERYTHEMATOSUS; POLYARTHRITIS; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID SURGERY; VASCULITIS;

EID: 0033003875     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050057     Document Type: Article

References (8)

1. Burrell CD, Fraser R, Doniach D. The low toxicity of carbimazole. Br Med J 1956;1:1453-7.
2. Cooper DS. Anti-thyroid drugs. N Engl J Med 1984;11:1953-62.
3. Ducornet B, Duprey J. Effets secondaires des antithyroidiens de synthèse. Ann Med Interne 1988;139:410-31.
4. Marine D, Baumann EJ. Periarteritis nodosa-like lesions in rats fed thiouracil. Arch Pathol 1945;39:325-30.
5. Shabtai R, Shapiro MS. Oreinstein D, Taragan R, Shekman L. The antithyroid arthritis syndrome reviewed. Arthritis Rheum 1984;27:227-9.
6. Tosun M, Güler M, Erem C, Uslu T, Miskioglu E. Intermittent polyarthritis due to propylthiouracil. Clin Rheumatol 1995;14:574-5.
7. Reidy TJ, Upshaw JD, Chesney TC. Propylthiouracil-induced vasculitis: a fatal case. South Med J 1982;75:1297-8.
8. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with prophylthiouracil therapy. Lancet 1993;342:651-2.